生存率-话题@MedSci

#生存率#

482篇内容 | 6583人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1256915, encodeId=1ee6125691592, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=超高生存率与疾病控制率，质子重离子精准放疗有效提高骨肉瘤患者预后！, objectType=article, longId=733739, objectId=4d54e3373952, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d54e3373952, replyNumber=0, likeNumber=199, createdTime=2022-07-30, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d54e3373952, moduleTitle=超高生存率与疾病控制率，质子重离子精准放疗有效提高骨肉瘤患者预后！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d54e3373952)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256909, encodeId=84fd12569090c, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=CGH: 治疗期间的氨基转移酶可预测自身免疫性肝炎患者的长期生存率, objectType=article, longId=733151, objectId=329ee33151fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=329ee33151fa, replyNumber=0, likeNumber=173, createdTime=2022-07-26, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=329ee33151fa, moduleTitle=CGH: 治疗期间的氨基转移酶可预测自身免疫性肝炎患者的长期生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=329ee33151fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256908, encodeId=e5e51256908fe, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Gastroenterology Report：术前CA125升高与接受原发性肿瘤切除的转移性结直肠癌患者的低生存率相关, objectType=article, longId=732677, objectId=e228e3267764, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e228e3267764, replyNumber=0, likeNumber=164, createdTime=2022-07-19, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e228e3267764, moduleTitle=Gastroenterology Report：术前CA125升高与接受原发性肿瘤切除的转移性结直肠癌患者的低生存率相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e228e3267764)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256907, encodeId=4de0125690e3e, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=J RENAL NUTR：血液透析患者身体组成的变化及其与患者生存率之间的关系, objectType=article, longId=732255, objectId=d8efe32255a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8efe32255a2, replyNumber=0, likeNumber=172, createdTime=2022-07-14, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8efe32255a2, moduleTitle=J RENAL NUTR：血液透析患者身体组成的变化及其与患者生存率之间的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8efe32255a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256906, encodeId=7ede125690646, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Lancet Regional Health：通过筛查检出的结直肠癌患者的生存率, objectType=article, longId=731998, objectId=80d6e3199886, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=80d6e3199886, replyNumber=0, likeNumber=183, createdTime=2022-07-12, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=80d6e3199886, moduleTitle=Lancet Regional Health：通过筛查检出的结直肠癌患者的生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80d6e3199886)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256910, encodeId=5d27125691081, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=平均5年生存率45%，美国治疗肺癌的前沿技术有哪些？, objectType=article, longId=731991, objectId=4d28e3199158, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d28e3199158, replyNumber=0, likeNumber=196, createdTime=2022-07-12, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d28e3199158, moduleTitle=平均5年生存率45%，美国治疗肺癌的前沿技术有哪些？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d28e3199158)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256911, encodeId=beac1256911f2, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=NCCN肝癌治疗临床指南前沿方案调整解析！新治疗方案生存率如何？, objectType=article, longId=731879, objectId=ad8de31879a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ad8de31879a3, replyNumber=0, likeNumber=201, createdTime=2022-07-11, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ad8de31879a3, moduleTitle=NCCN肝癌治疗临床指南前沿方案调整解析！新治疗方案生存率如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad8de31879a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256905, encodeId=bead12569058e, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Nat Med：胰腺癌免疫联合疗法，一年生存率增加近65%！, objectType=article, longId=729392, objectId=cb2ee293927d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb2ee293927d, replyNumber=0, likeNumber=181, createdTime=2022-06-15, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb2ee293927d, moduleTitle=Nat Med：胰腺癌免疫联合疗法，一年生存率增加近65%！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb2ee293927d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256904, encodeId=6fae12569048d, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Radiology：利用胸片的深度学习模型预测COPD患者生存率优于FEV1, objectType=article, longId=729127, objectId=42dbe29127f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=42dbe29127f3, replyNumber=0, likeNumber=115, createdTime=2022-06-12, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=42dbe29127f3, moduleTitle=Radiology：利用胸片的深度学习模型预测COPD患者生存率优于FEV1, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=42dbe29127f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256903, encodeId=9f861256903ce, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=ASCO 2022 | 慢性淋巴细胞白血病一线疗法：Calquence联合奥妥珠单抗持续生存获益：5年生存率达到90%！, objectType=article, longId=728833, objectId=026ae2883362, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=026ae2883362, replyNumber=0, likeNumber=129, createdTime=2022-06-09, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=026ae2883362, moduleTitle=ASCO 2022 | 慢性淋巴细胞白血病一线疗法：Calquence联合奥妥珠单抗持续生存获益：5年生存率达到90%！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=026ae2883362)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256902, encodeId=5dc11256902f4, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=ASCO：转移性胰腺癌患者化疗免疫治疗后生物特征与生存率的关系, objectType=article, longId=728269, objectId=0f7ce282691b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f7ce282691b, replyNumber=0, likeNumber=119, createdTime=2022-06-01, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f7ce282691b, moduleTitle=ASCO：转移性胰腺癌患者化疗免疫治疗后生物特征与生存率的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f7ce282691b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256901, encodeId=70271256901bb, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=2022 ASCO：免疫治疗时代，原发灶不明的恶性黑色素瘤患者生存率得到改善, objectType=article, longId=728231, objectId=69a9e28231d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69a9e28231d1, replyNumber=0, likeNumber=128, createdTime=2022-06-01, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69a9e28231d1, moduleTitle=2022 ASCO：免疫治疗时代，原发灶不明的恶性黑色素瘤患者生存率得到改善, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69a9e28231d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256900, encodeId=e419125690009, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAMA:二甲双胍对非糖尿病乳腺癌患者侵袭性疾病生存率的影响, objectType=article, longId=727994, objectId=6942e279944e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6942e279944e, replyNumber=0, likeNumber=113, createdTime=2022-05-29, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6942e279944e, moduleTitle=JAMA:二甲双胍对非糖尿病乳腺癌患者侵袭性疾病生存率的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6942e279944e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256898, encodeId=ae001256898a5, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Eur Urol Focus：基线健康相关生活质量可预测根治性膀胱切除术后的膀胱癌特异性生存率, objectType=article, longId=726589, objectId=410de265896f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=410de265896f, replyNumber=0, likeNumber=125, createdTime=2022-05-12, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=410de265896f, moduleTitle=Eur Urol Focus：基线健康相关生活质量可预测根治性膀胱切除术后的膀胱癌特异性生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=410de265896f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256897, encodeId=0f53125689e97, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAMA Cardiol：院外心脏骤停患者的10年生存率, objectType=article, longId=726358, objectId=dad3e26358ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dad3e26358ad, replyNumber=0, likeNumber=136, createdTime=2022-05-09, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dad3e26358ad, moduleTitle=JAMA Cardiol：院外心脏骤停患者的10年生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dad3e26358ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256899, encodeId=75871256899b2, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=JAMA Cardiol：急性心肌梗死患者的10年生存率, objectType=article, longId=726356, objectId=5c25e2635677, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c25e2635677, replyNumber=0, likeNumber=134, createdTime=2022-05-09, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c25e2635677, moduleTitle=JAMA Cardiol：急性心肌梗死患者的10年生存率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c25e2635677)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256896, encodeId=1c401256896ba, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Cancer Discovery：余棣华团队发现，维生素E能够提高癌症患者生存率，通过激活树突状细胞，增强癌症免疫治疗效果, objectType=article, longId=724442, objectId=6310e24442f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6310e24442f9, replyNumber=0, likeNumber=159, createdTime=2022-04-18, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6310e24442f9, moduleTitle=Cancer Discovery：余棣华团队发现，维生素E能够提高癌症患者生存率，通过激活树突状细胞，增强癌症免疫治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6310e24442f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256895, encodeId=b0ed1256895e2, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=Stroke：急性卒中后的长期生存率、卒中复发和预期寿命, objectType=article, longId=724357, objectId=fc10e2435740, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc10e2435740, replyNumber=0, likeNumber=128, createdTime=2022-04-17, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc10e2435740, moduleTitle=Stroke：急性卒中后的长期生存率、卒中复发和预期寿命, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc10e2435740)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256894, encodeId=4c1912568946d, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=AACR 2022：Sotorasib在KRAS G12C+ NSCLC的2年生存率上表现惊人, objectType=article, longId=724154, objectId=839ce2415432, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=839ce2415432, replyNumber=0, likeNumber=125, createdTime=2022-04-14, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=839ce2415432, moduleTitle=AACR 2022：Sotorasib在KRAS G12C+ NSCLC的2年生存率上表现惊人, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=839ce2415432)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1256893, encodeId=e58c1256893bd, content=<a href='/topic/show?id=43706900963' target=_blank style='color:#2F92EE;'>#生存率#</a>, objectTitle=AJH：急性髓性白血病强化化疗的生存率预测及其特征关联, objectType=article, longId=723823, objectId=9ce9e23823e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ce9e23823e7, replyNumber=0, likeNumber=108, createdTime=2022-04-10, rootId=0, userName=guoyibin, userId=6a6043, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ce9e23823e7, moduleTitle=AJH：急性髓性白血病强化化疗的生存率预测及其特征关联, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ce9e23823e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生存率

2020-05-29

guoyibin (审核中...)

前往app查看评论内容

#生存率#

超高生存率与疾病控制率，质子重离子精准放疗有效提高骨肉瘤患者预后！

2022-07-30

guoyibin (审核中...)

前往app查看评论内容

#生存率#

CGH: 治疗期间的氨基转移酶可预测自身免疫性肝炎患者的长期生存率

2022-07-26

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Gastroenterology Report：术前CA125升高与接受原发性肿瘤切除的转移性结直肠癌患者的低生存率相关

2022-07-19

guoyibin (审核中...)

前往app查看评论内容

#生存率#

J RENAL NUTR：血液透析患者身体组成的变化及其与患者生存率之间的关系

2022-07-14

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Lancet Regional Health：通过筛查检出的结直肠癌患者的生存率

2022-07-12

guoyibin (审核中...)

前往app查看评论内容

#生存率#

平均5年生存率45%，美国治疗肺癌的前沿技术有哪些？

2022-07-12

guoyibin (审核中...)

前往app查看评论内容

#生存率#

NCCN肝癌治疗临床指南前沿方案调整解析！新治疗方案生存率如何？

2022-07-11

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Nat Med：胰腺癌免疫联合疗法，一年生存率增加近65%！

2022-06-15

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Radiology：利用胸片的深度学习模型预测COPD患者生存率优于FEV1

2022-06-12

guoyibin (审核中...)

前往app查看评论内容

#生存率#

ASCO 2022 | 慢性淋巴细胞白血病一线疗法：Calquence联合奥妥珠单抗持续生存获益：5年生存率达到90%！

2022-06-09

guoyibin (审核中...)

前往app查看评论内容

#生存率#

ASCO：转移性胰腺癌患者化疗免疫治疗后生物特征与生存率的关系

2022-06-01

guoyibin (审核中...)

前往app查看评论内容

#生存率#

2022 ASCO：免疫治疗时代，原发灶不明的恶性黑色素瘤患者生存率得到改善

2022-06-01

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JAMA:二甲双胍对非糖尿病乳腺癌患者侵袭性疾病生存率的影响

2022-05-29

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Eur Urol Focus：基线健康相关生活质量可预测根治性膀胱切除术后的膀胱癌特异性生存率

2022-05-12

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JAMA Cardiol：院外心脏骤停患者的10年生存率

2022-05-09

guoyibin (审核中...)

前往app查看评论内容

#生存率#

JAMA Cardiol：急性心肌梗死患者的10年生存率

2022-05-09

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Cancer Discovery：余棣华团队发现，维生素E能够提高癌症患者生存率，通过激活树突状细胞，增强癌症免疫治疗效果

2022-04-18

guoyibin (审核中...)

前往app查看评论内容

#生存率#

Stroke：急性卒中后的长期生存率、卒中复发和预期寿命

2022-04-17

guoyibin (审核中...)

前往app查看评论内容

#生存率#

AACR 2022：Sotorasib在KRAS G12C+ NSCLC的2年生存率上表现惊人

2022-04-14

guoyibin (审核中...)

前往app查看评论内容

#生存率#

AJH：急性髓性白血病强化化疗的生存率预测及其特征关联

2022-04-10

科室
- - 订阅+
  - 更多科室
工具
服务